Compare · PGNY vs SHC
PGNY vs SHC
Side-by-side comparison of Progyny Inc. (PGNY) and Sotera Health Company (SHC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both PGNY and SHC operate in Misc Health and Biotechnology Services (Health Care), so they compete in similar markets.
- SHC is the larger of the two at $5.16B, about 2.4x PGNY ($2.11B).
- Over the past year, PGNY is up 39.0% and SHC is up 10.8% - PGNY leads by 28.2 points.
- PGNY has been more active in the news (5 items in the past 4 weeks vs 2 for SHC).
- Both have 25 recent analyst ratings on file.
- Company
- Progyny Inc.
- Sotera Health Company
- Price
- $26.88-2.06%
- $17.89-1.00%
- Market cap
- $2.11B
- $5.16B
- 1M return
- -0.43%
- -5.57%
- 1Y return
- +39.03%
- +10.80%
- Industry
- Misc Health and Biotechnology Services
- Misc Health and Biotechnology Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2019
- 2020
- News (4w)
- 5
- 2
- Recent ratings
- 25
- 25
Progyny Inc.
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Sotera Health Company
Sotera Health Company provides sterilization, and lab testing and advisory services to the medical device, pharmaceutical, and food products industries in the Americas, Europe and Asia. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.
Latest PGNY
- SEC Form 4 filed by Progyny Inc.
- Progyny to Present New Menopause Research at The Menopause Society 2026 Annual Meeting
- Progyny, Inc. Selling Season Pacing to Record Level, Revealing Critical Insights on Latest Market Dynamics
- EVP, GC Swartz Allison sold $101,868 worth of shares (3,903 units at $26.10) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 75,816 units (SEC Form 4)
- Chief Product Officer Clapp Geoffrey covered exercise/tax liability with 819 shares, decreasing direct ownership by 1% to 59,009 units (SEC Form 4) to cover taxes
- Amendment: Director Gordon Kevin K exercised 22,000 shares at a strike of $13.00, covered exercise/tax liability with 10,500 shares and sold $311,858 worth of shares (11,500 units at $27.12) (SEC Form 4)
- Director Gordon Kevin K exercised 22,000 shares at a strike of $13.00, covered exercise/tax liability with 10,500 shares and sold $321,358 worth of shares (11,500 units at $27.94) (SEC Form 4)
- SEC Form 144 filed by Progyny Inc.
- CHIEF EXECUTIVE OFFICER Anevski Peter covered exercise/tax liability with 5,361 shares, decreasing direct ownership by 0.66% to 806,111 units (SEC Form 4) to satisfy tax liability
- EVP, GC Swartz Allison covered exercise/tax liability with 1,307 shares, decreasing direct ownership by 2% to 79,719 units (SEC Form 4) (withholding tax)
Latest SHC
- Sotera Health downgraded by Analyst with a new price target
- Amendment: SEC Form SCHEDULE 13G/A filed by Sotera Health Company
- Executive Chairman Petras Michael B. Jr. sold $21,174,786 worth of shares (1,144,515 units at $18.50), decreasing direct ownership by 43% to 397,912 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by Sotera Health Company
- Sotera Health Company filed SEC Form 8-K: Leadership Update
- President of Sterigenics Rutz Michael P sold $2,825,250 worth of shares (150,000 units at $18.84), decreasing direct ownership by 31% to 334,279 units (SEC Form 4)
- Sr. Vice President, CFO Lyons Jonathan M. covered exercise/tax liability with 11,316 shares, decreasing direct ownership by 5% to 217,304 units (SEC Form 4) (tax liability)
- SEC Form 144 filed by Sotera Health Company
- SEC Form 10-Q filed by Sotera Health Company
- Sotera Health Company filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits